Investing for an epic future
Arc31 is the family office of Stuart Giles and Cathie Reid and their children and manages their portfolio of investments.
Stuart and Cathie are successful healthcare entrepreneurs who co-founded Icon Cancer Group, Epic Pharmacy Group and the Epic Good Foundation.
Arc31 manages their investments in a variety of portfolio companies and funds, with each investment selected for its potential to create value greater than just financial.
Arc31 Pharmacy Management
Arc31 Pharmacy Management supports the portfolio of pharmacies owned by Arc31 founders Cathie Reid and Stuart Giles.
Arc31 PM provides governance and leadership to the pharmacies and works closely with the Icon Group Pharmacy Management team overseeing the services they deliver.
AUCloud
AUCloud is Australia’s sovereign cloud Infrastructure-as-a-Service (IaaS) provider, exclusively focused on the Australian government and Critical National Industry communities.
Australian Premier League (APL)
Australian Premier League (APL) is a franchise-driven T20 club cricket tournament for junior and senior cricketers, where the best compete against the best in an event model based on the IPL. The inaugural competition will take place in 2021 via the Brisbane Premier League (BPL).
HEAL Partners
HEAL Partners is a follow on fund including early to mid-stage investments within the Health, Education and Lifestyle sectors.
Hello Alice
Hello Alice is a free digital platform that makes smart, instant connections between business owners and the resources they need to accelerate sustainable growth and global impact.
Qure Ventures
Qure is Israel’s first digital health focused fund.
Our Crowd
Our Crowd is a leading startup investment platform providing access to pre vetted startup opportunities alongside trusted venture capital and angel investors.
Afiniti
Afiniti transforms the way humans interact by applying artificial intelligence to discover, predict and affect patterns of interpersonal behaviour.
Impact Fund
The Impact Fund unlocks the power of mainstream investment capital to fund assets that create positive social and environmental impact.
Westpac World Bank Sustainable Growth Bonds
World Bank Sustainable Growth Bonds support the United Nations Sustainable Development Goals and provide an opportunity for investors to put their capital towards projects that advance these global development priorities.
Successful Exits
Icon Group
Icon Group is Australia’s largest dedicated provider of cancer care with a growing reach into Asia and New Zealand. The Group is built on a strong but simple vision to deliver the best care possible, to as many people as possible, as close to home as possible.
QScan
QScan is a leading provider of diagnostic imaging services across Australia.
Cathie
Cathie has always believed in the role digital solutions have to play in the delivery of exceptional healthcare, and this focus has driven not only her activity at Icon and Epic but sits behind many of the Arc31 investments.
In addition to her role at Arc31 she is the Chair of AUCloud and a Director of the Brisbane Lions Australian Rules Football Club.
Cathie is also keenly awaiting her flight to space as one of Virgin Galactic’s Future Astronauts, and documents that journey at her website here.
Stuart
Awarded the Norman Martin prize for Pharmacy Administration and Planning in 1991, Stuart has always had a keen interest in the business side of healthcare.
As Co-Founder and Chairman of Icon Group Stuart played a critical role in guiding the growth and vision of the group both locally and abroad and continues to play a leading role in Arc31’s other healthcare investments.
Sascha
Sascha is currently enrolled in BSc Business Management at King’s College London after completing a gap year internship with the Brand and Communications team at Icon Group. She recently visited Israel to meet with a number of the Our Crowd portfolio companies and is looking forward to continuing to expand her role at Arc31.
Sam
Sam’s high school studies remain his primary focus at present, but he maintains a keen interest in the selection and performance of Arc31’s investments.